Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
The absolute lymphocyte to monocyte ratio is associated with poor prognosis in classical Hodgkin lymphoma patients younger than 60 years of age.
[hodgkin lymphoma, classical]
Recent
studies
suggest
that
absolute
lymphocyte
count
,
absolute
monocyte
count
and
their
ratio
[
lymphocyte
/
monocyte
ratio
(
LMR
)
]
at
diagnosis
may
predict
survival
in
classical
Hodgkin
lymphoma
(
cHL
)
.
Here
,
we
investigated
the
prognostic
significance
of
LMR
in
cHL
patients
in
relation
to
age
of
patients
.
Subjects
included
351
cHL
patients
(
age
range
from
4
to
84
 
years
,
median
age
34
 
years
,
sex
ratio
1
.
58
)
who
had
been
followed-up
for
a
median
period
of
59
 
months
(
range
,
0
.
1
-
245
 
months
)
.
The
estimated
5
-
year
overall
survival
(
OS
)
rate
was
86
.
8
%
.
Subgroup
analysis
was
performed
according
to
patients
'
age
;
non-elderly
group
(
<
60
 
years
of
age
)
versus
elderly
group
(
≥
60
 
years
of
age
)
.
There
was
no
significant
difference
in
the
level
of
absolute
lymphocyte
count
,
absolute
monocyte
count
or
LMR
between
the
age
groups
.
Using
receiver
operating
characteristic
curve
analysis
,
the
optimal
cut-off
value
of
LMR
for
the
entire
cohort
was
determined
at
2
.
8
,
whereas
the
optimal
cut-off
for
the
elderly
group
was
2
.
2
.
In
the
non-elderly
group
(
<
60
 
years
old
)
,
patients
with
LMR
<
2
.
8
had
significantly
lower
OS
or
lymphoma
-
specific
survival
compared
with
those
with
LMR
≥
2
.
8
(
p
 
<
 
0
.
001
,
both
)
.
In
contrast
,
neither
the
LMR
value
of
2
.
8
or
2
.
2
predicted
survival
in
the
elderly
group
.
In
multivariate
analysis
,
LMR
remained
a
significant
prognostic
factor
for
OS
(
p
 
=
 
0
.
049
)
.
The
results
of
our
analysis
suggest
that
low
LMR
is
associated
with
poor
OS
in
patients
of
<
60
 
years
old
.
Copyright
©
2014
John
Wiley
&
Sons
,
Ltd
.
Diseases
Validation
Diseases presenting
"specific survival"
symptom
dedifferentiated liposarcoma
esophageal squamous cell carcinoma
hodgkin lymphoma, classical
liposarcoma
pleomorphic liposarcoma
well-differentiated liposarcoma
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom